The EU Commission exceptionally orders the licensing of a copyright to safeguard competition in the German pharmaceutical sales reports market (IMS Health)

"Commission exceptionally orders the licensing of a copyright to safeguard competition in the German pharmaceutical sales reports market"*1. Introduction On 3 July 2001 the Commission adopted an interim measures Decision finding that IMS Health [1], a US company selling pharmaceutical sales reports, had infringed Article 82. IMS had refused to grant licences to a ‘brick structure’, a copyrighted map dividing Germany into 1 860 segments used to present the data which form the reports. The Commission found that in the exceptional circumstances of the case, it was not possible to compete to sell such sales reports without using this structure. Given the likelihood that IMS would gain a lasting monopoly on the German market without urgent action, the Commission considered that the only

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Graham Zebedee, Corinne Dussart-Lefret, The EU Commission exceptionally orders the licensing of a copyright to safeguard competition in the German pharmaceutical sales reports market (IMS Health), 3 July 2001, e-Competitions July 2001, Art. N° 36960

Visites 342

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues